Results 11 to 20 of about 6,741,320 (294)
Congenital Heart Disease and Pulmonary Hypertension [PDF]
Heart Failure Clinics, 2012 Many patients with congenital heart disease and systemic-to-pulmonary shunts develop pulmonary arterial hypertension (PAH), particularly if the cardiac defect is left unrepaired. A persistent increase in pulmonary blood flow may lead to obstructive arteriopathy and increased pulmonary vascular resistance, a condition that can lead to reversal of shunt ...
Gupta, Vedant +2 more
openaire +3 more sources
Adults with congenital heart disease: the patients' perspective. [PDF]
Over the last 50 years technical and other advances have resulted in more than 90% of children born with congenital heart disease (CHD) surviving and reaching adulthood.
Lyon, Joy E.
core +9 more sources
ESC Heart Failure, 2021 Aims Pulmonary arterial hypertension (PAH) is common amongst patients with congenital heart disease (CHD). It is a severe and complex condition that adversely affects quality of life and prognosis.
Andrew Constantine +5 more
doaj +1 more source
Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease. [PDF]
, 2014 Background: Elevated plasma B-type natriuretic peptide (BNP) levels and their association with heart failure have been reported in subjects with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Oga, T +5 more
core +1 more source
A Case of Pulmonary Hypertension Recurred by Graves’ Disease [PDF]
Kosin Medical Journal, 2013 A few cases of severe pulmonary hypertension with right heart failure associated with Graves’ disease were reported in the literature. However, cases of pulmonary hypertension with right heart failure recurred by Graves’ disease is very rare. We describe
Jun Seop Lee +5 more
doaj +1 more source
The use of Macitentan in Fontan circulation: a case report
BMC Cardiovascular Disorders, 2017 Background The Fontan circulation, a result of a palliative procedure in patients with single systemic ventricles, is defined by chronically elevated pulmonary vascular resistance.
Polyvios Demetriades +4 more
doaj +1 more source
Adult congenital heart care in the COVID-19 era, and beyond: A call for actionKey Points
International Journal of Cardiology Congenital Heart Disease, 2020 While virus epidemics are nothing new to man, the scale, speed of global spread and immediacy of the COVID-19 pandemic have been truly unprecedented [1].
Michael A. Gatzoulis +8 more
doaj +1 more source
Nature Communications, 2023 Pulmonary hypertension worsens outcome in left heart disease. Stiffening of the pulmonary artery may drive this pathology by increasing right ventricular dysfunction and lung vascular remodeling.
Mariya M. Kucherenko +19 more
doaj +1 more source
Pulmonary heart disease in Ibadan [PDF]
Thorax, 1971 Pulmonary heart disease is encountered and is not uncommon in the tropics. The incidence of the chronic form is expected to increase, while the causes of the acute form may be different from those in temperate countries and so require different prophylactic measures.
openaire +2 more sources
Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. [PDF]
, 2005 BACKGROUND: Morbidity in COPD results from a combination of factors including hypoxia-induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal studies suggest a role of angiotensin II and acute studies in man concur.
Shakur, B Haleema +17 more
core +2 more sources